Hudson Portfolio Management LLC Invests $857,000 in Cardinal Health, Inc. $CAH

by · The Cerbat Gem

Hudson Portfolio Management LLC acquired a new position in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) in the second quarter, Holdings Channel reports. The institutional investor acquired 3,606 shares of the company’s stock, valued at approximately $857,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Bank of New York Mellon Corp acquired a new stake in shares of Cardinal Health during the second quarter valued at about $308,640,000. Kornitzer Capital Management Inc. KS lifted its holdings in shares of Cardinal Health by 100.8% in the 4th quarter. Kornitzer Capital Management Inc. KS now owns 18,164 shares of the company’s stock worth $3,733,000 after acquiring an additional 9,120 shares during the last quarter. Abacus FCF Advisors LLC acquired a new position in shares of Cardinal Health in the 4th quarter worth approximately $7,182,000. Byrne Financial Freedom LLC acquired a new position in shares of Cardinal Health in the 4th quarter worth approximately $1,574,000. Finally, Belleair Asset Management LLC purchased a new position in shares of Cardinal Health during the 4th quarter worth approximately $1,100,000. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Cardinal Health

In related news, insider Michelle D. Greene sold 11,650 shares of the business’s stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $235.72, for a total transaction of $2,746,138.00. Following the completion of the sale, the insider owned 10,330 shares in the company, valued at $2,434,987.60. The trade was a 53.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Jessica L. Mayer sold 29,436 shares of the company’s stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $236.19, for a total transaction of $6,952,488.84. Following the completion of the transaction, the insider owned 33,076 shares of the company’s stock, valued at approximately $7,812,220.44. The trade was a 47.09% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 210,271 shares of company stock worth $49,626,657. Corporate insiders own 0.12% of the company’s stock.

Cardinal Health Stock Up 0.4%

Shares of CAH stock opened at $229.48 on Friday. Cardinal Health, Inc. has a 52 week low of $145.87 and a 52 week high of $258.30. The stock has a market capitalization of $53.37 billion, a PE ratio of 31.74, a P/E/G ratio of 1.23 and a beta of 0.49. The firm has a 50 day moving average of $232.02 and a two-hundred day moving average of $217.86.

Cardinal Health (NYSE:CAH – Get Free Report) last posted its quarterly earnings results on Tuesday, August 11th. The company reported $2.91 EPS for the quarter, topping the consensus estimate of $2.42 by $0.49. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The business had revenue of $63.67 billion during the quarter, compared to the consensus estimate of $65.15 billion. During the same quarter in the previous year, the firm posted $2.08 earnings per share. The company’s quarterly revenue was up 5.8% compared to the same quarter last year. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. Analysts expect that Cardinal Health, Inc. will post 12.54 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be issued a dividend of $0.5158 per share. This represents a $2.06 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Thursday, October 1st. Cardinal Health’s payout ratio is 28.49%.

Key Headlines Impacting Cardinal Health

Here are the key news stories impacting Cardinal Health this week:

  • Positive Sentiment: Royal Bank of Canada initiated coverage with an “outperform” rating and a $276 price target, implying meaningful upside from recent trading levels. RBC cited Cardinal Health’s higher-margin services as a potential earnings-growth driver. RBC initiates coverage of Cardinal Health
  • Positive Sentiment: Wall Street remains broadly constructive, with 16 analysts rating CAH a Buy and three assigning a Hold rating. The consensus rating is “Moderate Buy,” with an average price target of approximately $266.56. Zacks also identified Cardinal Health as a potentially attractive long-term value stock. Zacks value-stock analysis
  • Positive Sentiment: Cardinal Health’s latest quarter delivered adjusted earnings per share of $2.91, well above the $2.42 consensus estimate, while revenue increased 5.8% year over year. Fiscal 2027 EPS guidance of $12.40–$12.60 supports the longer-term earnings case.
  • Neutral Sentiment: The company declared a quarterly dividend of $0.5158 per share, equivalent to $2.06 annually and a yield of about 0.9%. The payout offers modest income support but is unlikely to be a major near-term catalyst.
  • Negative Sentiment: Several executives sold sizable holdings around $235–$237 per share. CEO Jason Hollar sold 124,529 shares worth about $29.4 million, while other executive and insider sales—including those by Deborah Weitzman, Stephen Mason, Michelle Greene, Jessica Mayer and Mary Scherer—totaled roughly $20 million more. The concentrated selling and substantial reductions in insider ownership may encourage profit-taking concerns after CAH’s strong advance. Cardinal Health insider sales
  • Negative Sentiment: Investors may also question the durability of the latest earnings beat because part of the improvement reportedly reflected a one-time tariff refund, potentially limiting the stock’s upside if recurring earnings growth does not match expectations. Cardinal Health earnings analysis

Analyst Upgrades and Downgrades

CAH has been the subject of several research reports. Zacks Research downgraded shares of Cardinal Health from a “strong-buy” rating to a “hold” rating in a report on Friday, June 12th. Robert W. Baird upped their price target on Cardinal Health from $251.00 to $274.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 12th. Mizuho raised their price target on Cardinal Health from $240.00 to $250.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 12th. Wells Fargo & Company lifted their price objective on Cardinal Health from $245.00 to $277.00 and gave the company an “overweight” rating in a research note on Wednesday, August 12th. Finally, UBS Group boosted their price objective on Cardinal Health from $274.00 to $280.00 and gave the company a “buy” rating in a report on Wednesday, August 12th. Sixteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, Cardinal Health has an average rating of “Moderate Buy” and an average price target of $266.56.

Check Out Our Latest Research Report on Cardinal Health

Cardinal Health Company Profile

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

Featured Stories

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).